CTRI Number |
CTRI/2014/05/004596 [Registered on: 13/05/2014] Trial Registered Retrospectively |
Last Modified On: |
01/12/2015 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia |
Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
Public Title of Study
|
To compare the pain relief during labour using a epidural local anaesthetic and an opioid versus epidural local anaesthetic and opioid along with intravenous steroid(dexamethasone) |
Scientific Title of Study
|
Intravenous dexamethasone as an adjunct to patient-controlled epidural analgesia with levobupivacaine and fentanyl in labour: a randomized, double blind, placebo controlled study |
Trial Acronym |
None |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Pratibha dube |
Designation |
Post graduate junior resident |
Affiliation |
GMCH chandigarh |
Address |
Department of Anaesthesia and Intensive care,
Level 5, Block D
GMCH sector 32
Chandigarh
Chandigarh CHANDIGARH 160032 India |
Phone |
9815678146 |
Fax |
|
Email |
pratibhadube.dube@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Professor Sukanya Mitra |
Designation |
Professor |
Affiliation |
GMCH chandigarh |
Address |
Department of Anaesthesia and Intensive care,
Level 5, Block D
GMCH sector 32
Chandigarh
Chandigarh CHANDIGARH 160032 India |
Phone |
9646121521 |
Fax |
|
Email |
drsmitra12@yahoo.com |
|
Details of Contact Person Public Query
|
Name |
Dr Pratibha dube |
Designation |
Post graduate junior resident |
Affiliation |
GMCH chandigarh |
Address |
Department of Anaesthesia and Intensive care,
Level 5, Block D
GMCH sector 32
Chandigarh
Chandigarh CHANDIGARH 160032 India |
Phone |
9815678146 |
Fax |
|
Email |
pratibhadube.dube@gmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
GMCH chandigarh |
Address |
Department of Anaesthesia and Intensive care,
Level 5, Block D,
GMCH sector 32
Chandigarh |
Type of Sponsor |
Government medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Pratibha Dube |
GMCH, Chandigarh |
Department of Anaesthesia and Intensive care, Level-5, Block-D, GMCH, Sector-32, Chandigarh Chandigarh CHANDIGARH |
9815678146
pratibhadube.dube@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Research and Ethics Committee, GMCH Chandigarh |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
Age 18 years
Primigravida
Single gestation
Cephalic presentation at ≥ 36 wk of gestation
In early spontaneous labour (cervical dilation ≤ 5 cm)
Baseline pain score 30 (on a 0-100 VAS)
, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Placebo group |
This group will receive 50ml of normal saline 45 minutes before insertion of epidural catheter and will receive 10 ml of levobupivacaine 1mg/ml (0.1 percent) with 2μg/ml fentanyl epidural bolus followed by continuous background infusion of 5 ml of 0.1 percent of levobupivacaine with 2μg/ml of fentanyl. In addition, there will be a provision of patient-controlled bolus of 5 ml of 0.1 percent of levobupivacaine with 2μg/ml of fentanyl with a lock-out interval of 12min. |
Intervention |
Steroid group |
This group will receive dexamethasone 8mg intravenously diluted to 50 ml with normal saline 45 minutes before insertion of epidural catheter and will receive 10 ml of levobupivacaine 1mg/ml (0.1 percent) with 2μg/ml fentanyl epidural bolus followed by continuous background infusion of 5 ml of 0.1 percent of levobupivacaine with 2μg/ml of fentanyl. In addition, there will be a provision of patient-controlled bolus of 5 ml of 0.1 percent of levobupivacaine with 2μg/ml of fentanyl with a lock-out interval of 12min. |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
35.00 Year(s) |
Gender |
Female |
Details |
• American Society of Anesthesiologists (ASA) grade I and II
• Age >18 years
• Primigravida
• Single gestation
• Cephalic presentation at ≥ 36 wk of gestation
• In early spontaneous labour (cervical dilation ≤ 5 cm)
• Baseline pain score > 30 (on a 0-100 VAS)
• Able to use PCEA pump
• Requesting epidural analgesia for labour
|
|
ExclusionCriteria |
Details |
• Refusal by parturient.
• Parturients who had received parenteral opioids in the last 4 hours.
• Systemic and local sepsis.
• Deranged coagulation profile.
• Parturients having multiple pregnancies and premature labour.
• Obstetric complications (e.g., premature rupture of amniotic membranes).
• Noncephalic presentations.
• Allergy to study drugs, i.e. levobupivacaine and fentanyl.
• H/O peptic ulcer disease.
• Known case of uncontrolled Diabetes Mellitus.
• Patient who have received dexamethasone in last 7 days for foetal lung maturity.
|
|
Method of Generating Random Sequence
|
Random Number Table |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant and Investigator Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Hourly average consumption of levobupivacaine and fentanyl mixture, including both continuous background infusion plus bolus doses (in ml) corrected for the duration of labour. |
At the end of delivery |
|
Secondary Outcome
|
Outcome |
TimePoints |
Maternal satisfaction and Pain score (VAS)
|
Every 5 min for the first 20 min and then every 1 h until delivery, on a 0-100 scale. |
Haemodynamic parameters of mother |
5 min for the first 20 min and then every 1 h until delivery |
Sensory and motor block characteristics |
Sensory block at midline every 5 min for the first 20 min and then every 1 h until delivery.
Lower limb motor block every 5 min using the modified Bromage scale |
Foetal heart rate |
Continuous foetal heart rate monitoring. |
Apgar score |
1 and 5 minute after delivery |
|
Target Sample Size
|
Total Sample Size="80" Sample Size from India="80"
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
Modification(s)
|
01/06/2014 |
Date of Study Completion (India) |
Date Missing |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
Will be notified |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
Labour is the physiological process associated with severe pain, the multidimensional aspects and intensity of which far exceeds that of other conditions.Although severe pain in healthy parturient is not life-threatening, it can have numerous neuropsychological consequences.The goal of labour analgesia is to provide adequate pain relief without causing any maternal or foetal jeopardy. Continuous epidural analgesia is the most versatile and most commonly employed technique since it can be used for pain relief during labour and for subsequent vaginal delivery as well as analgesia and anaesthesia for ceasarean section, if necessary. The review of literature in the area of labour analgesia indicates that significant progress has been made with the advent of PCEA using a combination of low-concentration long-acting local anaesthetics (bupivacaine, levobupivacaine) and low-dose lipid soluble potent opioids (e.g., fentanyl).studying whether addition of a long-established safe and well-tolerated adjuvant in multimodal postoperative analgesia like dexamethasone by the intravenous route to the intrapartum labour analgesia regime reduces the total hourly consumption of the local anaesthetic-opioid combination by the epidural route. |